What does PHARMAYOU WANZE do?

PHARMAYOU WANZE is a pharmacy in Wanze. Public Limited, started on 31 December 1997, 1 establishment.

What is the address of PHARMAYOU WANZE?

The registered office of PHARMAYOU WANZE is located at Chaussée de Wavre(WAN) 6, 4520 Wanze.

Is PHARMAYOU WANZE still active?

Yes. According to the CBE (29 October 2026) PHARMAYOU WANZE is active, legal situation “Normale toestand”, started on 31 December 1997.

Is PHARMAYOU WANZE registered on Peppol?

Yes, PHARMAYOU WANZE is registered on the Peppol network with ID 0208:0462316945.

What is the enterprise number of PHARMAYOU WANZE?

The enterprise number of PHARMAYOU WANZE is BE0462316945.

When was PHARMAYOU WANZE founded?

PHARMAYOU WANZE was founded on 31 December 1997.

Who are the directors of PHARMAYOU WANZE?

According to the 2025 annual accounts, the directors of PHARMAYOU WANZE are: MOES SA, Francis MOES.

Is PHARMAYOU WANZE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 December 1997; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMAYOU WANZE make in 2025?

PHARMAYOU WANZE posted a profit after taxes of € 166,052 in financial year 2025.

What is the revenue of PHARMAYOU WANZE?

As a small company, PHARMAYOU WANZE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 962,287.

How much does an employee at PHARMAYOU WANZE earn?

The average wage cost per full-time employee at PHARMAYOU WANZE was € 76,100 in 2025: staff costs of € 532,509 for 7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMAYOU WANZE have?

According to the 2025 annual accounts, PHARMAYOU WANZE has 7 full-time equivalents (FTE).

PHARMAYOU WANZE (Public Limited) - Wanze - BE0462316945

Dossier PHARMAYOU WANZE, printed on 29 October 2026 from databakkes.be/en/0462316945/pharmayou-wanze. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMAYOU WANZE from Wanze, company number BE0462316945, closed financial year 2025 with a result of € 166,052 after tax. For that financial year PHARMAYOU WANZE recorded a gross margin of € 962,287 and equity of € 1.5 million. Compared with financial year 2024, the result moved from € 241,304 to € 166,052. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Growing

€ 1.5 million

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 166,052

▼ 31% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 339,229

▼ 20% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.4 million.

People and assets in 2025

Full-time equivalents

▼ 0.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 532,509

▲ 3% vs 2024

€ 76,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 17,993

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.1 million

▼ 7% vs 2024

€ 86,667 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 151,144

▼ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 56,806

▼ 14% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 596,679 Gross margin 2022: € 596,679 First fiscal year in the series	€ 650,282 Gross margin 2023: € 650,282 ▲ 9% vs 2022 (€ 596,679) Favourable step	€ 1,005,025 Gross margin 2024: € 1,005,025 ▲ 55% vs 2023 (€ 650,282) Favourable step	€ 962,287 Gross margin 2025: € 962,287 ▼ 4% vs 2024 (€ 1,005,025) Unfavourable step	▼ 4%
Profit after taxes	€ 12,399 Profit after taxes 2022: € 12,399 First fiscal year in the series	€ -181 Profit after taxes 2023: € -181 ▼ € 12,580 vs 2022 (€ 12,399) Unfavourable step	€ 241,304 Profit after taxes 2024: € 241,304 ▲ € 241,484 vs 2023 (€ -181) Favourable step	€ 166,052 Profit after taxes 2025: € 166,052 ▼ 31% vs 2024 (€ 241,304) Unfavourable step	▼ 31%
Equity	€ 1,052,993 Equity 2022: € 1,052,993 First fiscal year in the series	€ 1,052,813 Equity 2023: € 1,052,813 Unchanged (€ 1,052,993) Unfavourable step	€ 1,294,117 Equity 2024: € 1,294,117 ▲ 23% vs 2023 (€ 1,052,813) Favourable step	€ 1,460,169 Equity 2025: € 1,460,169 ▲ 13% vs 2024 (€ 1,294,117) Favourable step	▲ 13%
Total debts	€ 485,660 Total debts 2022: € 485,660 First fiscal year in the series	€ 1,873,139 Total debts 2023: € 1,873,139 ▲ 286% vs 2022 (€ 485,660) Unfavourable step	€ 1,786,794 Total debts 2024: € 1,786,794 ▼ 5% vs 2023 (€ 1,873,139) Favourable step	€ 1,621,334 Total debts 2025: € 1,621,334 ▼ 9% vs 2024 (€ 1,786,794) Favourable step	▼ 9%
Cash	€ 287,640 Cash 2022: € 287,640 First fiscal year in the series	€ 240,074 Cash 2023: € 240,074 ▼ 17% vs 2022 (€ 287,640) Unfavourable step	€ 424,739 Cash 2024: € 424,739 ▲ 77% vs 2023 (€ 240,074) Favourable step	€ 339,229 Cash 2025: € 339,229 ▼ 20% vs 2024 (€ 424,739) Unfavourable step	▼ 20%
Land & buildings	€ 705,425 Land & buildings 2022: € 705,425 First fiscal year in the series	€ 2,048,390 Land & buildings 2023: € 2,048,390 ▲ 190% vs 2022 (€ 705,425) Unchanged	€ 2,068,310 Land & buildings 2024: € 2,068,310 ▲ 1% vs 2023 (€ 2,048,390) Unchanged	€ 2,018,093 Land & buildings 2025: € 2,018,093 ▼ 2% vs 2024 (€ 2,068,310) Unchanged	▼ 2%
Retained profit	€ 991,020 Retained profit 2022: € 991,020 First fiscal year in the series	€ 990,813 Retained profit 2023: € 990,813 Unchanged (€ 991,020) Unfavourable step	€ 1,232,117 Retained profit 2024: € 1,232,117 ▲ 24% vs 2023 (€ 990,813) Favourable step	€ 1,398,169 Retained profit 2025: € 1,398,169 ▲ 13% vs 2024 (€ 1,232,117) Favourable step	▲ 13%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 1,237,310 Bank debt 2023: € 1,237,310 Unchanged (€ 0) Unfavourable step	€ 1,155,556 Bank debt 2024: € 1,155,556 ▼ 7% vs 2023 (€ 1,237,310) Favourable step	€ 1,068,889 Bank debt 2025: € 1,068,889 ▼ 7% vs 2024 (€ 1,155,556) Favourable step	▼ 7%
Balance sheet total	€ 1,557,693 Balance sheet total 2022: € 1,557,693 First fiscal year in the series	€ 2,944,516 Balance sheet total 2023: € 2,944,516 ▲ 89% vs 2022 (€ 1,557,693) Unchanged	€ 3,148,836 Balance sheet total 2024: € 3,148,836 ▲ 7% vs 2023 (€ 2,944,516) Unchanged	€ 3,146,092 Balance sheet total 2025: € 3,146,092 Unchanged (€ 3,148,836) Unchanged
Employees (FTE)	8.6 Employees (FTE) 2022: 8.6 First fiscal year in the series	7.6 Employees (FTE) 2023: 7.6 ▼ 1 vs 2022 (8.6) Unchanged	7.8 Employees (FTE) 2024: 7.8 ▲ 0.2 vs 2023 (7.6) Unchanged	7 Employees (FTE) 2025: 7 ▼ 0.8 vs 2024 (7.8) Unchanged	▼ 0.8

Key figures of PHARMAYOU WANZE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMAYOU WANZE?

What happened at PHARMAYOU WANZE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 166,052 (▼ 31% vs 2024). filed late Source: NBB ↗
Mar 12, 1998 New establishment in Wanze. KBO
Dec 31, 1997 Start of the company according to the CBE. KBO

In short

From € 12,399 profit in 2022 to € 166,052 profit in 2025.

Paid € 49,827 in corporate taxes since 2022.

Best year ever: 2024, with € 241,304 profit.

On average € 137,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

MOES 100%

The stake of MOES comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMAYOU WANZE

Behind PHARMAYOU WANZE are MOES SA and Francis MOES. The shares are held by MOES (100%).

Directors

According to the 2025 annual accounts

MOES SA

Director · represented by Corinne BLISTIN

Also active at: PHARMAYOU GLONS, Pharmacie d'Oupeye - Bernard, PHARMAYOU WAREMME SAINT-ELOI

Francis MOES

Director

Shareholders

MOES

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Chaussée de Wavre(WAN) 6

4520 Wanze

2.085.847.715

Place François Faniel(WAN) 10

4520 Wanze

Active since 12 March 1998

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0462.316.945

VAT number

BE 0462.316.945

Registered office

Chaussée de Wavre(WAN) 6, 4520 Wanze

Names & denominations

PHARMAYOU WANZE

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

31 December 1997

Peppol

Active · Active since 19 Sept 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Groothandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMAYOU WANZE

Financials

What happened to PHARMAYOU WANZE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions